Innovation shown to demonstrate reduction in headaches and neck pain

TEL AVIV – Israel-based Headway Medical has reported the completion of a series of clinical trials of Occiflex, its therapeutic table designed to reduce chronic neck pain and headaches. The device will be available to physiotherapy clinics and rehabilitation centers throughout the world next year.

"Occiflex will make the work of 50,000 physiotherapy and pain centers around the world more efficient and provide relief for the hundreds of millions who suffer from chronic neck pain and headaches. It will also save physiotherapists time and energy, and permit them to treat a number of patients simultaneously,"said Tamir Levital, CEO of Headway.

According to a Headway Medical press release, Occiflex supports slow, repeated, and precise treatment for patients with muscle-dysfunction-related chronic pain. The table’s mechanism allows physiotherapists to devise a manual mobilization file tailored to each patient’s needs. Furthermore, since it does not depend on the therapist’s physical abilities, the device can continue therapy for much longer than is standard and possible today. The patient’s file can also be modified at any time as conditions merit. The treatment table improves the condition of the cervical joints, muscle, ligaments, and central nervous system control over the neck and head.

The results of the clinical trial were published in the Clinical Journal of Pain. The trial, conducted in the physiotherapy department of the Bnei Zion Medical Center in Haifa, Israel, tested the advanced prototype developed by the company. Results demonstrated reduced chronic neck pain in the patients, as well as increased mobility.